Inventor · disambiguated record
Kirk W. Johnson
Also filed as: JOHNSON KIRK · JOHNSON KIRK W · JOHNSON KIRK WILLIAM
29 granted patents·27 pending applications·294 citations·filing 1999–2024
96Inventor score
Top patents by PatentIndex Score
56 records- 0195US7425557B2Inhibitors of glycogen synthase kinase 3NOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Sep 16, 2008·19 cites·24 claims
- 0294US7045519B2Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 2001·Granted May 16, 2006·46 cites·44 claims
- 0393US7037918B2Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 2002·Granted May 2, 2006·49 cites·3 claims
- 0492US7749490B2Mutant IL-10UNIV COLORADO·Filed 2006·Granted Jul 6, 2010·34 cites·4 claims
- 0590US6489344B1Inhibitors of glycogen synthase kinase 3CHIRON CORP·Filed 1999·Granted Dec 3, 2002·76 cites·34 claims
- 0689US11752096B2Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumorsAMMAX BIO INC·Filed 2022·Granted Sep 12, 2023·1 cites·18 claims
- 0789US7829549B2Methods for treating bleeding disorders using sulfated polysaccharidesBAXTER INT·Filed 2009·Granted Nov 9, 2010·9 cites·15 claims
- 0888US11419822B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2021·Granted Aug 23, 2022·1 cites·13 claims
- 0987US7585875B2Substituted pyrazolo[1,5-a]pyridine compounds and their methods of useAVIGEN INC·Filed 2007·Granted Sep 8, 2009·8 cites·9 claims
- 1085US7767654B2Methods for treating bleeding disorders using sulfated polysaccharidesBAXTER INT·Filed 2005·Granted Aug 3, 2010·5 cites·9 claims
- 1184US9234051B2Methods for fucoidan purification from seaweed extractsBAXTER INT·Filed 2014·Granted Jan 12, 2016·11 cites·13 claims
- 1281US6638927B2GuanidinobenzamidesCHIRON CORP·Filed 2001·Granted Oct 28, 2003·16 cites·14 claims
- 1380US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 1480US2025073170A1High concentration formulations of anti-csf1 and anti-csf1r antibodiesAMMAX BIO INC·Filed 2024·Application pending·0 cites
- 1579US7915285B2Method for treating drug and behavioral addictionsUNIV COLORADO·Filed 2006·Granted Mar 29, 2011·6 cites·53 claims
- 1677US12178915B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2022·Granted Dec 31, 2024·0 cites·10 claims
- 1775US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 1874US12371501B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·11 claims
- 1973US8748595B2Methods for fucoidan purification from sea weed extractsSHAKLEE PATRICK N·Filed 2008·Granted Jun 10, 2014·5 cites·25 claims
- 2073US2024158535A1Parathyroid hormone receptor 1(pth1r) antibodies and uses thereofXOMA US LLC·Filed 2023·Application pending·0 cites
- 2172US2024016730A1Targeted delivery of anti-csf1r antibodiesAMMAX BIO INC·Filed 2023·Application pending·0 cites
- 2271US11427641B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Aug 30, 2022·0 cites·5 claims
- 2371US10519250B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2017·Granted Dec 31, 2019·1 cites·34 claims
- 2470US11787876B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2019·Granted Oct 17, 2023·0 cites·24 claims
- 2566US10711067B2Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgeryXOMA US LLC·Filed 2016·Granted Jul 14, 2020·1 cites·24 claims
- 2666US7534806B2Method for treating neuropathic pain and associated syndromesAVIGEN INC·Filed 2005·Granted May 19, 2009·2 cites·15 claims
- 2764US2010035920A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEAVIGEN INC·Filed 2009·Application pending·0 cites
- 2864US2009318437A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEGAETA FEDERICO C A·Filed 2009·Application pending·0 cites
- 2964US2022142662A1Streamlined Treatment of Clot Removal, Angioplasty and Prevention of Restenosis Using a Single Integrated Intravascular DeviceDEPUY SYNTHES PRODUCTS INC·Filed 2022·Application pending·0 cites
- 3063US2009098185A1Method for treating thrombotic disorders using sulfated polysaccharidesAVIGEN INC·Filed 2008·Application pending·0 cites
- 3162US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 3260US2024199752A1Treatment of ophthalmic diseasesJOHNSON KIRK WILLIAM·Filed 2022·Application pending·0 cites
- 3359US2023152330A1Detection and treatment of idiopathic pulmonary fibrosisAMMAX BIO INC·Filed 2022·Application pending·0 cites
- 3456US8420697B2Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefromMATSUDA KAZUKO·Filed 2012·Granted Apr 16, 2013·0 cites·30 claims
- 3556US2008114027A1Method for treating deliriumJOHNSON KIRK W·Filed 2007·Application pending·0 cites
- 3655US2009221629A1Method for antagonizing MIF activityAVIGEN INC·Filed 2009·Application pending·0 cites
- 3754US8771973B2Methods for treating bleeding disorders using sulfated polysaccharidesJOHNSON KIRK W·Filed 2011·Granted Jul 8, 2014·0 cites·3 claims
- 3854US7622256B2Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1AVIGEN INC·Filed 2007·Granted Nov 24, 2009·0 cites·1 claims
- 3954US2014056999A1Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefromMEDICINOVA INC·Filed 2013·Application pending·0 cites
- 4053US2015051191A1Treatment of alcoholism using ibudilastMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 4152US8859526B2Methods for treating bleeding disorders using sulfated polysaccharidesJOHNSON KIRK W·Filed 2010·Granted Oct 14, 2014·0 cites·8 claims
- 4252US2008107678A1Method for treating thrombotic disorders using sulfated polysaccharidesJOHNSON KIRK W·Filed 2007·Application pending·0 cites
- 4351US2018251562A1Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat HypoglycemiaXOMA US LLC·Filed 2018·Application pending·0 cites
- 4449US2011117213A1Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefromMEDICINOVA INC·Filed 2010·Application pending·0 cites
- 4549US2013178495A1Ibudilast for relieving negative effects of medication overuse headacheADELAIDE RES & INNOVATION PTY·Filed 2012·Application pending·0 cites
- 4649US2007191365A13,4,6-Substituted pyridazines for treating neuropathic pain and associated syndromesSULTZBAUGH LANCE·Filed 2007·Application pending·0 cites
- 4747US2003229025A1Intranasal administration of MC4-R agonistsCHIRON CORP·Filed 2003·Application pending·0 cites
- 4846US2007004743A1Intranasal administration of mc4-r agonistsXIAO LINDA L·Filed 2003·Application pending·0 cites
- 4946US2009209575A1Method for treating neuropathic pain and associated syndromesJOHNSON KIRK W·Filed 2009·Application pending·0 cites
- 5045US2012295982A1Treating human male copd patients with oral bedoradrineJOHNSON KIRK W·Filed 2012·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kirk W. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →